Revenue
2022
2023
2024
2025
Proteome Sciences plc (PRM)
Price£0.0140Cached quote
Net income
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | £3.8M | £4.9M | £5.0M | £7.8M | — |
| Operating expenses | £2.6M | £3.0M | £3.3M | £3.0M | — |
| Operating income | −£2.7M | −£2.4M | −£1.6M | £1.7M | — |
| Operating margin | −70.98% | −48.15% | −32.24% | 22.21% | — |
| EBITDA | −£1.7M | −£1.5M | −£1.1M | £2.0M | — |
| EBITDA margin | −46.33% | −31.00% | −22.61% | 25.86% | — |
| Net income | −£3.1M | −£3.4M | −£2.4M | £1.3M | — |
| Net profit margin | −81.50% | −69.70% | −48.59% | 17.03% | — |
| Basic EPSper basic share | — | -£0.01 | -£0.01 | £0.00 | £0.00 |
| Diluted EPSper diluted share | — | -£0.01 | -£0.01 | £0.00 | £0.00 |